Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Vanda Pharmaceuticals
VNDA
$280M
| $558K | ﹤0.01% |
80,809
-110,227
| -58% | -$850K |
2013 Q2
51 quarters
|
|
3102
Napco Security Technologies
NSSC
$1.29B
| $557K | ﹤0.01% |
14,145
-54,813
| -79% | -$2.3M |
2019 Q1
28 quarters
|
|
3103
Dorman Products
DORM
$3.66B
| $557K | ﹤0.01% |
5,337
-37,727
| -88% | -$4.49M |
2016 Q1
40 quarters
|
|
|
CBIO
3104
Crescent Biopharma
CBIO
$532M
| $555K | ﹤0.01% |
+30,189
| New | +$347K |
2026 Q1
0 quarters
|
|
3105
Flywire
FLYW
$2.14B
| $554K | ﹤0.01% |
47,577
-549,718
| -92% | -$6.92M |
2022 Q1
16 quarters
|
|
|
SEMR
3106
DELISTED
Semrush
SEMR
| $552K | ﹤0.01% |
46,238
-50,334
| -52% | -$598K |
2022 Q1
16 quarters
|
|
3107
SGHC Ltd
SGHC
$5.71B
| $552K | ﹤0.01% |
51,113
-358,907
| -88% | -$3.66M |
2022 Q4
13 quarters
|
|
|
MNTN
3108
MNTN Inc
MNTN
$741M
| $550K | ﹤0.01% |
62,540
+53,214
| +571% | +$532K |
2025 Q3
2 quarters
|
|
3109
Diebold Nixdorf
DBD
$2.17B
| $550K | ﹤0.01% |
7,294
-31,278
| -81% | -$2.3M |
2023 Q4
9 quarters
|
|
3110
SI-BONE Inc
SIBN
$810M
| $550K | ﹤0.01% |
43,564
-58,828
| -57% | -$920K |
2018 Q4
29 quarters
|
|
|
GLDD
3111
DELISTED
Great Lakes Dredge & Dock
GLDD
| $549K | ﹤0.01% |
32,318
-106,982
| -77% | -$1.7M |
2016 Q4
37 quarters
|
|
|
UHT
3112
Universal Health Realty Income Trust
UHT
$509M
| $549K | ﹤0.01% |
13,569
-17,745
| -57% | -$736K |
2013 Q2
51 quarters
|
|
3113
Buckle
BKE
$2.21B
| $549K | ﹤0.01% |
10,901
-45,791
| -81% | -$2.37M |
2013 Q2
51 quarters
|
|
3114
Bank7 Corp
BSVN
$528M
| $548K | ﹤0.01% |
13,747
-4,728
| -26% | -$200K |
2018 Q3
30 quarters
|
|
3115
Investar Holding Corp
ISTR
$405M
| $548K | ﹤0.01% |
20,087
-14,815
| -42% | -$414K |
2017 Q1
36 quarters
|
|
3116
TFS Financial
TFSL
$4.72B
| $547K | ﹤0.01% |
38,965
+12,277
| +46% | +$174K |
2013 Q2
51 quarters
|
|
|
SEPN
3117
Septerna Inc
SEPN
$1.76B
| $546K | ﹤0.01% |
22,714
-15,433
| -40% | -$406K |
2024 Q4
5 quarters
|
|
3118
BCB Bancorp
BCBP
$262M
| $546K | ﹤0.01% |
60,758
-20,582
| -25% | -$168K |
2022 Q2
15 quarters
|
|
3119
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$732M
| $545K | ﹤0.01% |
+13,350
| New | +$560K |
2026 Q1
0 quarters
|
|
3120
Pebblebrook Hotel Trust
PEB
$2.15B
| $543K | ﹤0.01% |
43,009
-178,167
| -81% | -$2.18M |
2013 Q2
51 quarters
|
|
3121
OppFi
OPFI
$509M
| $542K | ﹤0.01% |
70,319
-6,404
| -8% | -$58.6K |
2022 Q2
15 quarters
|
|
|
GOLD
3122
Gold.com Inc
GOLD
$1.23B
| $540K | ﹤0.01% |
13,473
-21,554
| -62% | -$1.05M |
2020 Q2
23 quarters
|
|
3123
Twist Bioscience
TWST
$12.5B
| $540K | ﹤0.01% |
11,359
-182,712
| -94% | -$8.19M |
2018 Q4
29 quarters
|
|
3124
Surgery Partners
SGRY
$1.74B
| $538K | ﹤0.01% |
45,125
-201,841
| -82% | -$2.9M |
2015 Q4
41 quarters
|
|
3125
nLIGHT
LASR
$2.34B
| $534K | ﹤0.01% |
9,363
-64,396
| -87% | -$3.49M |
2018 Q2
31 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.